SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-036833
Filing Date
2019-02-13
Accepted
2019-02-13 06:14:32
Documents
3
Effectiveness Date
2019-02-13

Document Format Files

Seq Description Document Type Size
1 DEFA14A d697016ddefa14a.htm DEFA14A 16995
2 GRAPHIC g697016000dsp002.jpg GRAPHIC 6775
3 GRAPHIC g697016g0213090710192.jpg GRAPHIC 2435
  Complete submission text file 0001193125-19-036833.txt   31204
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35405 | Film No.: 19593165
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences